Bio-Strategy Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Bio-Strategy's estimated annual revenue is currently $10.5M per year.(i)
  • Bio-Strategy's estimated revenue per employee is $102,000

Employee Data

  • Bio-Strategy has 103 Employees.(i)
  • Bio-Strategy grew their employee count by 0% last year.

Bio-Strategy's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Marketing, ANZReveal Email/Phone
3
Purchasing OfficerReveal Email/Phone
4
Customer Service OfficerReveal Email/Phone
5
Executive DirectorReveal Email/Phone
6
Senior Product ManagerReveal Email/Phone
7
Product ManagerReveal Email/Phone
8
Product Manager (Oceania)Reveal Email/Phone
9
Service ManagerReveal Email/Phone
10
Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M16525%N/AN/A
#2
$8.8M864%N/AN/A
#3
$11.2M110-2%N/AN/A
#4
$10.5M1030%N/AN/A
#5
$13.7M134-6%N/AN/A
#6
$8.3M813%N/AN/A
#7
$27.2M2425%N/AN/A
#8
$64M5026%N/AN/A
#9
$110.2M772N/AN/AN/A
#10
$57.9M4548%N/AN/A
Add Company

What Is Bio-Strategy?

Delivering technology. Supplying specialist scientific instrumentation, equipment and consumables to the scientific and diagnostic markets in Australia, New Zealand and the South Pacific. We offer sales, applications support and technical service for all our products. Our key agencies include One Lambda Inc., Hamilton Company, Hamilton Robotics, Molecular Devices, Qiagen (NZ Only), Leica (NZ only), Priorclave, UVP, Labogene, and Kaltis.

keywords:N/A

N/A

Total Funding

103

Number of Employees

$10.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bio-Strategy News

2022-04-20 - Seegene Maps US Diagnostics Expansion With New Hires ...

"We're embarking on a major investment strategy in the US to become ... of that firm's future diagnostics strategies with Bio-Rad executives...

2022-04-19 - Solid Biosciences Announces Updated Corporate Strategy to ...

Strategy and resource alignment support funding of operations ... SGT-001 is based on pioneering research in dystrophin biology by Dr.

2022-04-19 - BridgeBio strategy head departs amid company's 2nd round of ...

BridgeBio strategy head departs amid company's second round of layoffs this year ... BridgeBio's chief strategy officer is headed for the exits as...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A10422%N/A
#2
$18.9M1052%N/A
#3
$30.7M1065%N/A
#4
$17.4M1091%N/A
#5
$15.8M109-5%N/A